Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Begoña Treceño"'
Autor:
Álvaro Díaz, Begoña Treceño, Elsa M. Valdizán, Angel Pazos, Elena Castro, Jesús Pascual-Brazo, Fuencisla Pilar-Cuéllar, Rebeca Vidal
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
It has been recently suggested that activation of 5-HT4 receptors might exert antidepressant-like effects in rats after 3 d treatment, suggesting a new strategy for developing faster-acting antidepressants. We studied the effects of 3 d and 7 d treat
Autor:
Jesús Pascual-Brazo, Castro Fernández, María Elena, Díaz Martínez, Álvaro, Valdizán Ruiz, Elsa María, Fuencisla Pilar-Cuéllar, Rebeca Vidal, Begoña Treceño, Pazos Carro, Ángel
Publikováno v:
The international journal of neuropsychopharmacology, 2012, 15(5), 631-643
It has been recently suggested that activation of 5-HT4 receptors might exert antidepressant-like effects in rats after 3 d treatment, suggesting a new strategy for developing faster-acting antidepressants. We studied the effects of 3 d and 7 d treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2473::74ba8d0b2d37afb27fa35364ab1fc15e
https://hdl.handle.net/10902/29397
https://hdl.handle.net/10902/29397
Autor:
Jesús, Pascual-Brazo, Elena, Castro, Alvaro, Díaz, Elsa M, Valdizán, Fuencisla, Pilar-Cuéllar, Rebeca, Vidal, Begoña, Treceño, Angel, Pazos
Publikováno v:
The international journal of neuropsychopharmacology. 15(5)
It has been recently suggested that activation of 5-HT₄ receptors might exert antidepressant-like effects in rats after 3 d treatment, suggesting a new strategy for developing faster-acting antidepressants. We studied the effects of 3 d and 7 d tre
Autor:
Elena Castro, Verónica Inés Vargas, Elsa M. Valdizán, A. Rodríguez-Gaztelumendi, Fuencisla Pilar-Cuéllar, Ricardo Mostany, Álvaro Díaz, Raquel Linge, Begoña Treceño, Severiano dos Anjos, Angel Pazos, Rebeca Vidal
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
ResearcherID
instname
ResearcherID
Over the past five decades, the pharmacological treatment of depression has been based on the pathophysiological hypothesis of a deficiency in monoamines, mainly serotonin and noradrenaline. Antidepressants prescribed today, all of them designed to e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9aee12ff27d59220e069d72a24b916f9
http://hdl.handle.net/10261/49481
http://hdl.handle.net/10261/49481